Alnylam Issues 2023 Corporate Responsibility Report
Go back to Alnylam Issues 2023 Corporate Responsibility Report| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 220.33 +14.81 (7.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $205.52 | 52 Week High | $109.10 | |||
| Open | $208.04 | 52 Week Low | $31.38 | |||
| Day High | $220.49 | P/E | N/A | |||
| Day Low | $208.04 | EPS | $-1.45 | |||
| Volume | 3,399,883 | |||||
